Detalhe da pesquisa
1.
Viruses, parkinsonism and Parkinson's disease: the past, present and future.
J Neural Transm (Vienna)
; 129(9): 1119-1132, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036863
2.
Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome.
J Neurol
; 271(1): 59-70, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37999770
3.
Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial.
Neurol Res Pract
; 6(1): 16, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509608
4.
Neurological symptoms after COVID-19 vaccination: a report on the clinical presentation of the first 50 patients.
J Neurol
; 270(10): 4673-4677, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515731
5.
The Park Sleep subtype in Parkinson's disease: from concept to clinic.
Expert Opin Pharmacother
; 24(15): 1725-1736, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561080
6.
The Gut Dysmotility Questionnaire for Parkinson's disease: Insights into development and pretest studies.
Front Neurol
; 14: 1149604, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37056364
7.
Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside.
Int Rev Neurobiol
; 165: 17-34, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208899
8.
Rotigotine Transdermal Patch for Motor and Non-motor Parkinson's Disease: A Review of 12 Years' Clinical Experience.
CNS Drugs
; 35(2): 215-231, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33559846